Monday, March 16, 2020

For nurses, a bad situation has gotten worse
© Erin Clark/The Boston Globe via Getty Images

Nurses detailed a lack of coordination between governments and hospitals over protocols that could help stem the outbreak, with mask shortages a notable example

Nurses were already working at full capacity before the outbreak, and many are facing a choice between paying their bills and calling in sick if they get exhausted or even catch the coronavirus.

In the case of a "domino effect" where nurses begin to get sick, one nurse warned, a nurse staffing crisis will only make the current health crisis worse.

Maeleigh Soper, a registered travel nurse in Seattle, has been rationing masks and hand sanitizers for the past week.

She said her hospital, which went through a month's worth of masks and hand sanitizers in three days, suspects that patients and families have been stealing medical supplies amid the novel coronavirus outbreak.

The novel coronavirus, which spread from China in late December, has since infected at least 169,000 people in every continent besides Antarctica.

US localities and businesses have taken steps to lessen the disease's spread, so that the health care system won't be overwhelmed by new patients. But Business Insider talked to nine nurses in hospitals nationwide, who said equipment shortages are putting their health and that of their patients at risk, as the novel coronavirus continues to spread.

Hospitals cannot limit the number of patients a nurse can legally care for at once in every state except for California, and nurses who care for more than six patients in a day get burned out and cannot provide adequate patient care, according to research from Linda Aikens. Nurses reported grappling with equipment shortages, understaffing, and a lack of coordination on protocols between health systems and the government.

"I think the real message we need to tell people is that this is the calm before the storm," Marcia Santini, a registered nurse at an emergency room in California, told Business Insider. "We need to keep our health care workers healthy, and if they get sick, that would collapse the health care system."Nurses are facing mask shortages - and they have called on the government and hospital systems for more resources

Santini said her hospital was crowded and nearly filled to occupancy - before the coronavirus outbreak.

Like Soper, Santini said her hospital has had a shortage of proper medical supplies like gowns and masks. On March 10, the National Nurses United union called on the White House and hospital systems to ensure that nurses have enough protective equipment. A union survey found only 30% of nurses report having enough equipment to deal with the virus outbreak.

Soper works in her hospital's oncology department, where patients receiving bone marrow transplants have severely comprised immune systems. Soper said her biggest fear is passing on the virus, potentially deadly to patients with comorbidities, to her patients.

"We need to be protected because once you start the domino effect," Santini said, referring to one health care worker getting sick and spreading the disease to other staffers, "then you're going to have a staffing crisis."
© AP Photo/Ted S. Warren

Nurses described feeling frustrated at the lack of coordination from hospitals and the government over proper protocol

Monica, a registered nurse who works in a rural hospital in Washington state, identified four patients last week who she thought should have been tested for COVID-19. (Business Insider confirmed Monica's identity before publishing this article).

But due to confusion from the state's Department of Health and hospital providers, none received a test.

The first man to die from coronavirus in the US lived in a long-term care facility in Washington state. Health care workers and other residents in the nursing home were also exposed to the virus.

Monica's hospital, which has already faced staffing shortages, asked her to work extra shifts on top of her six continuous night shifts. Coupled with a lack of proper protective gear, Monica told Business Insider she was frustrated by the lack of coordination between federal and state governments and hospital systems on figuring out coronavirus protocols.

Marie Spaner, a hospital nurse in the Los Angeles area, told Business Insider that she also felt frustrated at her hospital's lack of planning. Her hospital has not changed cleaning or sanitation protocols since the outbreak, nor has it limited visitors.

"It's frustrating and frightening. If we can't have things implemented properly in the hospital then it's a danger for us [nurses] and to the patients," Spaner told Business Insider. "We're just grossly unprepared."  
 
© Reuters 

For nurses themselves, getting sick means losing pay

Many nurses told Business Insider that if they take time off work, they won't get paid.

Carmen Martinez, who works as a nurse in the registry department in a California hospital, said her hospital recently stopped screening patients with fevers below 104 - even if they present other coronavirus symptoms.

Without screening patients for coronavirus when their temperature is below 104 - coupled with the shortages of protective equipment - Martinez said she was worried most about getting sick and needing to take time off work. Two weeks without work means Martinez won't be able to pay her bills.

"I don't think America knows how much how much is at stake for us," Martinez told Business Insider. "We're putting our lives at risk right now. I think everybody needs to remember that we're in the front lines were at risk, but there has to be provision made for us."
WE ALL WONDERED
Why toilet paper has become the latest coronavirus panic buy

By Scottie Andrew, CNN 3/9/2020

Masks were the first to go. Then, hand sanitizers.© Peter Parks/AFP/Getty Images Shelves are empty of toilet rolls in a supermarket in Sydney on March 4, 2020. - Australia's biggest supermarket announced a limit on hand sanitisers and toilet paper purchases after the global spread of coronavirus sparked a spate of panic buying Down Under.

Now, novel coronavirus panic buyers are snatching up ... toilet paper?

Retailers in the US and Canada have started limiting the number of toilet paper packs customers can buy in one trip. Some supermarkets in the UK are sold out. Grocery stores in Australia have hired security guards to patrol customers.
© WILLIAM WEST/AFP/Getty Images Supermarkets in Australia are largely selling out of toilet paper due to novel coronavirus fears. An Australian newspaper even printed out eight extra pages in a recent edition to serve as emergency toilet paper.

An Australian newspaper went so far as printing eight extra pages in a recent edition -- emergency toilet paper, the newspaper said, should Aussies run out.


Why? Toilet paper does not offer special protection against the virus. It's not considered a staple of impending emergencies, like milk and bread are.

So why are people buying up rolls more quickly than they can be restocked?


Reason 1



People resort to extremes when they hear conflicting messages

Steven Taylor is a clinical psychologist and author of "The Psychology of Pandemics," which takes a historic look at how people behave and respond to pandemics. And compared to past pandemics, the global response to the novel coronavirus has been one of widespread panic.

"On the one hand, [the response is] understandable, but on the other hand it's excessive," Taylor, a professor and clinical psychologist at the University of British Columbia, told CNN. "We can prepare without panicking."

The novel coronavirus scares people because it's new, and there's a lot about it that's still unknown. When people hear conflicting messages about the risk it poses and how seriously they should prepare for it, they tend to resort to the extreme, Taylor said.

"When people are told something dangerous is coming, but all you need to do is wash your hands, the action doesn't seem proportionate to the threat," he said. "Special danger needs special precautions."


Reason 2



Some are reacting to the lack of a clear direction from officials

Several countries have already imposed mass quarantines. People buying up toilet paper and other household supplies may be preparing for the same thing in their city, said Baruch Fischhoff, a psychologist and professor in the Department of Engineering and Public Policy and the Institute for Politics and Strategy at Carnegie Mellon University.

"Unless people have seen ... official promises that everyone will be taken care of, they are left to guess at the probability of needing the extra toilet paper, sooner rather than later," he told CNN. "The fact that there are no official promises might increase those probabilities."




Reason 3



Panic buying begets panic buying

Images of empty shelves and shopping carts piled high with supplies have inundated news reports and social feeds. People see images of panic buyers, assume there's a reason to panic and buy up supplies, too, Taylor said.

"People, being social creatures, we look to each other for cues for what is safe and what is dangerous," he said. "And when you see someone in the store, panic buying, that can cause a fear contagion effect."

All those photos of empty shelves may lead people to believe that they must rush out and grab toilet paper while they still can. And what started as perceived scarcity becomes actual scarcity, Taylor said.

Social media is a huge player in novel coronavirus fear-mongering, Taylor said. Misinformation spreads with ease, and open platforms amplify voices of panic.


Reason 4



It's natural to want to overprepare

There may be some practicality in stocking up, says Frank Farley, a professor at Temple University and former president of the American Psychological Association.

With the CDC and other international health agencies now advising that certain populations should stay home and avoid contact with other people or crowds, it's natural to want to prepare, he said.

"[The novel coronavirus] is engendering a sort of survivalist psychology, where we must live as much as possible at home and thus must 'stock up' on essentials, and that certainly includes toilet paper," he told CNN. "After all, if we run out of [toilet paper], what do we replace it with?"

You'll be spending money on toilet paper at one point or another -- the only extra costs are the hassle of doing it sooner rather than later, contending with long lines and having difficulty finding it, Fischhoff said.

Since they'll eventually use the toilet paper, the analysis is different than if they'd bought something they likely wouldn't use, like a perishable item, he said.

The US Department of Homeland Security advises Americans to keep at least two weeks' worth of food, toiletries and medical supplies on hand anyway, but Taylor said most people don't. So when health officials publicly advise to stock up, they may take it to the extreme.


Reason 5



It allows some to feel a sense of control

The people who are stocking up on supplies are thinking about themselves and their family and what they need to do to prepare, Taylor said -- not healthcare workers, sick people or even regular folks who might run out of toilet paper sometime soon.

"It's all due to this wave of anticipatory anxiety," Taylor said. "People become anxious ahead of the actual infection. They haven't thought about the bigger picture, like what are the consequences of stockpiling toilet paper."

But people only act that way out of fear. Fischhoff said that preparing, even by purchasing toilet paper, returns a sense of control to what seems like a helpless situation.

"Depending on how people estimate the chances of needing the toilet paper, the hassle might be worth it," he said. "If it gave them the feeling that they had done everything that they could, it might free them to think about other things than coronavirus."
Amazon launches business selling automated checkout to retailers

By Jeffrey Dastin
3/9/2020



Shopping carts are pictured during a tour of an Amazon checkout-free, large format grocery store in Seattle, Washington, U.S. February 21, 2020. Picture taken February 21, 2020. REUTERS/Jason Redmond


Shopping carts are pictured during a tour of an Amazon checkout-free, large format grocery store in Seattle, Washington, U.S. February 21, 2020. Picture taken February 21, 2020. REUTERS/Jason Redmond

March 9 (Reuters) - Amazon.com Inc on Monday is set to announce a new business line selling the technology behind its cashier-less convenience stores to other retailers, the company told Reuters.

The world's biggest web retailer said it has "several" signed deals with customers it would not name. A new website Monday will invite others to inquire about the service, dubbed Just Walk Out technology by Amazon.

The highly anticipated business reflects Amazon's strategy of building out internal capabilities - such as warehouses to help with package delivery and cloud technology to support its website - and then turning those into lucrative services it offers others.

Its chain Amazon Go has brought shopping without checkout lines into the mainstream, and the market for retail without cashiers - one of the most common vocations in the United States - could grow to $50 billion, U.S. venture firm Loup Ventures has estimated.

Dilip Kumar, Amazon's vice president of physical retail and technology, had no market forecast to share but said shoppers' preferences will determine how big the business becomes.

"Do customers like standing in lines?" he asked. "This has pretty broad applicability across store sizes, across industries, because it fundamentally tackles a problem of how do you get convenience in physical locations, especially when people are hard-pressed for time."

Unlike Amazon Go stores, shoppers will insert a credit card into a gated turnstile to enter, rather than scan an app. The turnstiles will display the logo "Just Walk Out technology by Amazon," but all other branding and store aspects will be controlled by the retailer using the service.

Items picked up by a customer and any guests who enter with them will be added to the shopper's virtual cart. The store will then bill the credit card once the person or group leaves the store - no bar code scans or checkout lines necessary.

Kumar said Amazon will install the technology including ceiling cameras and shelf weight sensors at retailers' stores, whether they are new locations or retrofits, and it will have a 24-7 support line.

COURTING RIVALS?

A by-product of demand for the offering would be increased usage of Amazon Web Services, the company's cloud that underpins its checkout-free systems.

Still, high demand is by no means certain. Other vendors including Grabango and AiFi are offering automated checkout to retailers, which in the past have been loath to hand deals to their rival Amazon that has been the biggest disruptor of their brick-and-mortar businesses.

Media reports have said Amazon was in talks to bring its technology to airport stores, for instance, rather than to Walmart Inc or Target Corp. Kumar said Amazon "potentially" could sell the service to big box rivals but would not speculate.

He declined to comment on the service's business model or pricing, saying, "a lot of those are bespoke deals."

One issue that may arise is who owns the shopper data, something that businesses typically want in order to tailor marketing offers and build their customer base.

Shoppers who desire a receipt will be able to type their email into a kiosk at any store. Amazon will send receipts to that address each subsequent time the credit card is used at a Just Walk Out location, no matter the retailer. Kumar said Amazon saves the email address and ties that to the credit card information, solely for the purpose of charging the customer.

Kumar would not discuss whether or how Amazon would integrate this into retailers' loyalty programs but said, "These are the retailers' customers."

"We prohibit the use of Just Walk Out technology data for anything other than supporting Just Walk Out retailers," he said.

(Reporting By Jeffrey Dastin in San Francisco; Editing by Daniel Wallis)
A new Dr. Seuss book will be published in September "Dr. Seuss's Horse Museum" by Dr. Seuss, illustrated by Andrew Joyner.

By Colette Bancroft, Tampa Bay Times
3/9/2020

© Penguin/Tampa Bay Times/TNS
 "Dr. Seuss's Horse Museum" by Dr. Seuss, illustrated by Andrew Joyner.

You know Dr. Seuss books helped make your kids smart.

And now there's a new one that's all about art!

Wait, a new Dr. Seuss book? The beloved children's author and illustrator, whose real name was Theodor Geisel, died in 1991. But Random House Children's Books has announced that it will publish a new book by him on Sept. 3.

According to an email: "The original manuscript for 'Dr. Seuss's Horse Museum' was discovered in the late author's La Jolla, Calif., home 21 years after his death, alongside the manuscript for the 2015 No. 1 New York Times best-seller "What Pet Should I Get?"

Seuss left notes and sketches for "Horse Museum," but not a finished book. His publishers worked with Australian illustrator Andrew Joyner, whose books include The Hair Book and the Duck and Hippo series, to re-create Seuss' unique visual style.

"Dr. Seuss's Horse Museum" also reflects Seuss' intense interest in modern art, and the book will incorporate full-color images of horse-themed works by such artists as Pablo Picasso, Rosa Bonheur, Alexander Calder, Jacob Lawrence and Jackson Pollock.

Dr. Seuss has been the target of some recent criticism, with studies showing that some of the images of people of color in his books use racist stereotypes. In 2017, the National Education Association rebranded its 20-year-old literacy program Read Across America, centered on his books and his March 2 birthday, to de-emphasize his work.

But he remains a beloved author, and many communities and schools in Read Across America continue to include his books.

"Dr. Seuss's Horse Museum" will have a first printing of 250,000 copies

Coronavirus truthers prey on the anxiety of the moment
© Provided by Yahoo! News Former Milwaukee County Sheriff David Clarke speaks at the Conservative Political Action Conference. (AP Photo/Susan Walsh File)© Yahoo News

As the global coronavirus outbreak continues to shutter businesses and schools across America and upend the stock market, a number of commentators on the right have been busily floating conspiracy theories about what’s behind the outbreak, or even how real it is.

“People should ask themselves whether this coronavirus ‘pandemic’ could be a big hoax, with the actual danger of the disease massively exaggerated by those who seek to profit — financially or politically — from the ensuing panic,” former Rep. Ron Paul wrote on his website Monday.

The former Republican presidential candidate, a physician and the father of Sen. Rand Paul, described Dr. Anthony Fauci, the leading scientific voice on President Trump’s coronavirus task force, as one of many government “fearmongers” who were part of a plan to institute martial law and permanently strip Americans of their rights.

Comments like Paul’s have stoked internet rumors about what’s to come and led more mainstream politicians, like Sen. Marco Rubio, R-Fla., to attempt to calm fears over the government’s response, albeit with spelling errors.

Please stop spreading stupid rumors about marshall (SIC) law.

COMPLETELY FALSE

We will continue to see closings & restrictions on hours of non-essential businesses in certain cities & states. But that is NOT marshall (SIC) law.
— Marco Rubio (@marcorubio) March 16, 2020

Paul is not the only coronavirus truther on the right. Former Milwaukee Sheriff David Clarke, who was floated as a possible candidate for a Trump administration post at the Department of Homeland Security, sounded the alarm on Sunday about what he saw as “an exploitation of a crisis.”

GO INTO THE STREETS FOLKS. Visit bars, restaurants, shopping malls, CHURCHES and demand that your schools re-open. NOW!

If government doesn’t stop this foolishness...STAY IN THE STREETS.

END GOVERNEMNT CONTROL OVER OUR LIVES. IF NOT NOW, WHEN?
THIS IS AN EXPLOITATION OF A CRISIS.
— David A. Clarke, Jr. (@SheriffClarke) March 15, 2020

Clarke then raised the specter that the right’s favorite bogeyman, banker George Soros, might be behind the pandemic.

Not ONE media outlet has asked about George Soros’s involvement in this FLU panic. He is SOMEWHERE involved in this.

— David A. Clarke, Jr. (@SheriffClarke) March 15, 2020

Shortly thereafter, Clarke announced that he was “LEAVING TWITTER DUE TO THEIR CONSERVATIVE SPEECH CONTROL.”

Barstool Sports founder Dave Portnoy has described himself as a “corona truther” who sees COVID-19 as nothing worse than the flu.

“It’s like a common cold,” Portnoy, whose website depends on business-as-usual in the sports and entertainment world, said on Jan. 30.

On March 11, Gavin Heavin, the co-founder of the fitness company Curves International, appeared on fellow conspiracy theorist Alex Jones’s program to promote a view heard on the fringes of the right-wing media: that coronavirus was engineered by enemies of the president to discredit him.

“We know that it’s a weaponized virus because we see the RNA strands that were put into this virus from HIV, from MERS and from the SARS virus. There’s no way this could have happened in nature.”

Coronavirus, according to Heavin, was produced by those “who want to destroy Trump’s presidency.” But Heavin, whose business will be hit hard as millions of Americans avoid exercising in gyms, went even further.

“I’m trying to get to Trump to make him aware that this is not a nonevent. This is a very nefarious act against him,” Heavin said, adding, “This virus was designed to kill primarily Asian people. Now the problem is it’s going to kill a lot of Europeans and non-Asian people because it’s still lethal. But that’s one more evidence that it was designed as a bioweapon to attack China.”

Taking a different, although equally conspiratorial, view of the matter, Sen. Tom Cotton, R-Ark., posited that the coronavirus originated at a secret Chinese biological lab near Wuhan, the city where it was first detected.

Tom Cotton reiterates his suggestion that the Coronavirus originated at a super-lab in Wuhan pic.twitter.com/i1cSNSqU0d

— Acyn Torabi (@Acyn) February 16, 2020

Zhao Lijian, deputy director of China’s foreign ministry of information, took to Twitter to promote the conspiracy theory that the virus originated in America and was first spread in his country by U.S. soldiers visiting Wuhan province.

Rubio, meanwhile, continued to try to steer the truthers’ focus back to the task at hand.

It won’t change anything but wanted to leave it for the record

Given what #COVID19 did to #China & now #Italy political potshots from all sides are really trivial

If we don’t change the trajectory of our current infection rate, in a few days no one will care about politics — Marco Rubio (@marcorubio) March 16, 2020


Trump finds his MAGA movement fracturing over coronavirus
By Tina Nguyen 

Just two weeks after President Donald Trump rallied conservatives to focus on the threat of socialism, his followers are splintering over the coronavirus pandemic.
© Brian Blanco/Getty Images President Donald Trump.

On one side are those like Bill Mitchell, who dismiss it as nothing worse than the flu, and the drive to eradicate it as “climate change 2.0” — as in, a media-lefty mass hysteria. On the other side are pro-Trump fixtures like Trump campaign adviser Jason Miller, who had been sounding the alarms on the coronavirus since January, and are calling for harsher lockdowns and urging social distancing.

While the MAGA movement is divided over how seriously to take the coronavirus threat or how to tackle it, the message among his supporters is increasingly unanimous: If Trump fails to control the virus, prevent its spread and prove his leadership, much less save the economy, he will lose the election and cripple his movement.

Trump’s supporters elected him because he was a “wartime leader” who could fight against the swamp and the elites, so they expect the same against a truly invisible threat, said War Room host and former Breitbart editor Raheem Kassam. “If, for a second, people think that he doesn't have that strength, or he doesn't have that fortitude, then it will become a problem,” he said.

The mounting health and economic risks from the coronavirus outbreak present a monumental political challenge for a group vowing to Make America Great Again. With just under eight months to go before a presidential election, Trump’s followers face the prospect that their core message — about deconstructing the “deep state” of government workers and transforming the nation’s power structure to serve everyday Americans — could collapse in a crisis environment.

“I would think that the very pro-Trump people maybe would like to downplay this, but actually, I don't even think that,” said Chris Buskirk, the editor-in-chief of the nationalist magazine American Greatness. “Because on this particular issue, the nationalist-MAGA crowd are all over the place. It’s totally individual.”

The divide was in stark contrast on Fox News last week, as the crisis snowballed into the public eye. One host, Tucker Carlson, delivered grave warnings about the coronavirus. He accused officials — who his conservative audience “probably voted for” — of minimizing “what is clearly a very serious problem.” Another host, Sean Hannity, called it “fear-mongering by the deep state.”

Across Trump world are other attempts to deflect blame — following an approach used by the president himself in recent weeks, as he attacked the Obama administration and others outside his administration for his team’s response.

Jerry Falwell Jr. suggested that North Korea created the virus. A conference promising “supernatural protection from the CoronaVirus” [sic] through the “blood and power of Jesus” initially advertised that Trump’s White House faith adviser, Paula White, would speak. (White is not attending.) And the more grounded, less conspiratorial-minded in the Trump base still found ways to take aim at the Democrats and the media.

On Sunday night, as Joe Biden and Bernie Sanders were debating the response to the virus, Breitbart’s snarky homepage headlines questioned whether the septuagenarians were up to the challenge, while Newsmax’s John Cardillo openly targeted conservatives who were “enabling” the “leftists salivating at the power grab COVID-19 presents.”

“80% of these cases are mild, meaning you get common cold, like people are recovering. I just don't see the need for all the panic,” said Students for Trump founder Ryan Fournier, who praised the fact that Trump’s speech in the Rose Garden raised the Dow by nearly 2,000 points. (They were under pressure overnight.)

The other half of MAGAland is urging their peers to look at the bigger picture.

“If you take that perspective, that it’s just the flu and it’s roughly the same thing that other people are going to get, and it’s probably going to have the same outcome, why would you want to have two separate viruses like that circulating at the same time as you can on that assumption?” Buskirk countered separately, worried about the potential strain on hospitals. (Admittedly, he joked, he had also been preparing for catastrophic events since 9/11.)

Other prominent figures in the loose confederacy of pro-Trump media recognized the potential for trouble. “That would be a massive vulnerability … if he started downplaying the disease again, and it were to get worse,” agreed Will Chamberlain, a pro-Trump commentator and the editor-in-chief of Human Events.

“Every president has the sort of out-of-the blue instances that happen that you can’t really plan for and it tests your leadership ability. It tests everything,” conceded Fournier. “And I think it is a fair assessment to say that the president has to exert strength here.”

Seth Mandel, the editor-in-chief of the conservative Washington Examiner magazine, noted that the rapid flip on the right from triumphal unity to existential terror happened in less than two weeks.

“I think, for a while, there was some degree of harmony in the conservative press,” he observed, pointing to the potential of Bernie Sanders as the Democratic presidential nominee bringing consensus to the movement prior to Super Tuesday. “If you're debating policy, then it looks like everybody’s pretty much on the same page, because whatever people think of Trump, they also don’t like socialism to a great degree.”

But over the next two weeks, that future shattered with the one-two punch of Joe Biden trouncing every candidate during the next 22 primaries, placing Sanders’s campaign on death watch, and the sudden, complete shutdown of Italy over coronavirus fears, leading to Trump’s decision to shut down travel between much of Europe and the U.S. And now much of the nation is shutting down to save itself from the rapidly spreading outbreak.

While they applauded Trump’s earlier decision to ban travel from China, they still could not overlook the lack of testing and the CDC’s inability to mount a strong prevention campaign against the virus, and some criticized Trump’s initial messaging.

“Trump was comparing flu statistics to coronavirus statistics,” said Chamberlain. “Well, that’s the same mistake that people make when they say, ‘Why do you care more about terrorism? Terrorism kills so many fewer people in car accidents every year.’ The answer is, ‘Because if something goes really wrong in terrorism, they could do unbelievably dramatic damage.’ Same logic here.”

There was a consensus among Trump’s supporters that the crisis was precipitated by the two things that Trump had long railed against: open borders and the over-reliance on Chinese manufacturing. With the coronavirus, argued Chamberlain, Trump was proven right: Lax border security had allowed the virus to spread, and the shutdown of Chinese factories, particularly the ones that manufactured medical supplies and medicine, hobbled America’s ability to fight it.

“If Trump wants to pursue his normal, original nationalist agenda, there's nothing about the coronavirus crisis that would preclude him from doing so. If anything, it is evident that his agenda is the right one to pursue.”

While coronavirus presented a custom-built argument for economic nationalism, it was not the argument that Trump initially made — something that did not escape Mandel, who was flabbergasted that Trump did not spin himself as a “prophet” and instead tried to downplay it. “When the president had a crisis that hit that would have, theoretically, been designed perfectly for the nationalist argument, he didn't reach for it. So maybe he doesn't really believe it.”

Trump’s Friday afternoon speech in the Rose Garden, in which Trump announced a national emergency and displayed several private corporations to aid the CDC’s response, heartened his supporters, who applauded the fact that there was, at least, a conservative-friendly plan to combat the virus: a website for people seeking information about COVID-19, a public-private partnership with several corporations to fight the disease and, most importantly, the declaration of a national emergency, freeing up billions in federal funding. (The website, however, was not quite what Trump had initially sold: What was initially early discussions about a Bay Area pilot program for health care workers run by a Google-affiliated startup was inflated to a Google website with 1,700 employees that could help people self-screen for COVID-19 symptoms.)

To be sure, the health of the economy is indeed one factor in Trump’s re-election — a bar, Kassem pointed out, that the Trump campaign set for itself by touting the strength of the economy for the past three years as proof positive of his leadership. But most would forgive him if he didn’t restore the Dow to its recent soaring heights, as long as the markets were stable.

Fournier pointed to Trump’s post-address market rebound as proof that Trump was truly in control. “Today it’s a good day in America. Declaring a national emergency, releasing those funds, working with these other companies — this is the holistic solution,” he said.

Mandel doubted that Trump would lose the percentage of his base that would be with him no matter what during the coronavirus pandemic, but cautioned that Trump could not rely on press conferences and bolstering the economy forever.

“There’s the public health thing, and then there’s the economy part of it, and everybody should really be caring about the public health thing the most, but even he needs to presumably get some credit if the economy doesn’t tank,” he said. “And if it looks like he tried to save the economy at the expense of the public health aspect of it — if voters think that’s what he did, and also he failed at both — then yeah, you can imagine that it’s absolutely a real threat to his reelection. And again, he doesn't have Bernie to lean back on.”
Former heavyweight champion Leon Spinks is fighting his toughest competitor yet: Cancer

Image result for leon spinksImage result for leon spinks

HENDERSON, Nev. — Leon Spinks has trouble swallowing these days, so his wife, Brenda, crushes the seven pills he takes every morning, dissolves them in water and loads them into a syringe. She injects the contents into the retired boxer’s feeding tube.

In June, Spinks, 66, was diagnosed with prostate cancer. He underwent three rounds of chemotherapy but the cancer spread to his bones. In November, Brenda said, one of the doctors treating Spinks said he had a about two weeks to live.

But Spinks, who shocked the sports world in 1978 when he upset Muhammad Ali and won the heavyweight championship of the world, is still fighting.

"He's a champion, he's going to keep fighting,''’ Brenda said recently as her husband maneuvered around their house with a walker.

Spinks, who also suffers from dementia, still flashes his famous smile and it's no longer gap-toothed. His missing front teeth were replaced years ago. Spinks recently started smoking marijuana in an effort to improve his mood and make him more compliant while working with a team of medical health professionals.

The couple's two-bedroom, three-bathroom house, about 20 miles south of Las Vegas, is replete with photos from Spinks’ boxing career, which include a gold medal from the 1976 Olympics and the heavyweight world championship.

Spinks made $320,000 for his first fight against Ali and more than $3 million for the rematch, according to published reports. There were no other big paydays after Ali won the second fight by unanimous decision.

Brenda, his third wife after they married in 2011, said Spinks has held private autograph sessions -- one scheduled for next month -- that the couple needs to help offset medical costs.

"When I met him, he didn't have anything," Brenda said.

In January, Spinks started taking Zytiga, a medication for people who have prostate cancer and already have undergone chemotherapy. The first bottle of 120 pills was a free sample, but Brenda said the doctor told her 120 pills cost $8,000.

“I think you can get it cheaper,’’ she said. “I don’t know. I haven’t gotten that far yet.’’

About five years ago, following emergency surgery after he swallowed a small piece chicken bone that punctured his intestines, Spinks began lacing up boxing gloves and hitting the heavy bag as part of his rehab. The expectations are far more modest now and the demands are far greater, Brenda said.

Her 29-year-old son, Michael, has moved in with the couple to provide help, and they have a caregiver seven days a week. Brenda also said she has gotten support from Spinks' brother, Michael, the former heavyweight and light heavyweight boxing champion; Spinks' sister, Karen, who spent a month in Henderson; Spinks' sons, Corey and Daryl; Spinks' grandson Leon Spinks III; and Brenda's sister, Sherry.

And there’s ever-present Sam, a black Labrador retriever trained by America’s VetDogs. (Spinks qualified for the service dog because he served in the Marine Corp from 1973 to 1976.) Brenda said Sam got depressed when Spinks was in the hospital and a few times jumped into the hospital bed when visiting Spinks.

"He was so excited to see Leon,'' Brenda said.

USA TODAY Sports spent a day recently with Leon and Brenda Spinks and part of the team working to keep Spinks alive.

At his fighting weight'

Spinks emerged from the bedroom wearing a “Neon Leon’’ T-shirt that bore the image of his face and famous grin from four decades ago. His once-protruding belly was gone.

Over the past year, Brenda said, Spinks has lost 80 pounds and is down to 194 pounds.

“He’s at his fighting weight again,’’ she said. “And boy, has he been fighting with everyone.’’

She smiled.

A framed colored print of Spinks and Ali, painted by famed artist LeRoy Neiman, hangs in the living room and is one of the reminders of the epic victory.

On Feb. 15, 1978, Spinks, then 24, climbed into the boxing ring at the Hilton Hotel in Las Vegas with a 6-0-1 record and as an overwhelming underdog. Ali, then 36, had a record of 55-2 with 37 knockouts.

Spinks scored a stunning split-decision, 15-round victory. Amid bedlam in the ring, he closed his eyes and waved his arms above his head in celebration.

Now he is often in a wheelchair.

Nasha Shigmatsu, a home health nurse, arrived at about 12:30 p.m. and Spinks' mood had darkened.

“Oh, no,'' Brenda said, "he’s turned on me.''

She reached into a bag and handed her husband a joint.

Two months after his victory over Ali, Spinks was charged with felony possession of cocaine and misdemeanor possession of marijuana. At one time, Brenda said, she used to throw out marijuana Spinks got from fans. But about a year ago, Brenda said, she started allowing him to use the drug that’s legal in Nevada.

She said he usually smokes no more than one joint a day.

“I’m so against it and now I’m going to dispensaries to buy it,’’ Brenda said. “It’s the only way I can get him to cooperate."

After a few puffs, Spinks allowed the nurse begin the exam.

“I need you to take deep breath for me, Leon,’’ the the nurse said. “Deep breath.’’

Spinks complied.

'You're showing off'

Spinks talks sparingly these days, other than brief exchanges with his wife that Brenda said most people find hard to understand. Sometimes his actions say everything the medical team needs to know, like when the physical therapist worked with him recently.

She walked alongside Spinks as he used his walker to move through the house.

“Big steps," the physical therapist said. “Good."

But Spinks he took an unexpected turn and headed from the living room into the backyard. Then circled through the master bedroom, continued through the house and onto the front porch. Ignoring the physical therapist's instructions to turn around, Spinks shuffled onto the driveway until he got to the black van with the wheelchair lift in the back.

“You’re showing off," the physical therapist said.

When the session ended, the physical therapist estimated Spinks had walked for 25 minutes – his personal record since returning from the hospital about 2½ months ago.

“Come on, Leon, high five," the physical therapist said.

Spinks scowled at the women’s raised right hand.

He also refused to take off his cap when a hairdresser arrived, and Brenda tried to coax Spinks to let her cut the back of her hair.

“You’re not cutting my hair,’’ he said, and no one had trouble understanding him.
A rescue mission

After being diagnosed with prostate cancer, Spinks seemed to be doing better after three rounds of chemotherapy — until blood was found in his urine. On Aug. 21 he was admitted to the hospital, and he spent almost four months there and experienced multiple complications, according to Brenda.

Spinks suffered from aspiration pneumonia, a staph infection, sepsis, inflammation of the colon and showed early signs of renal failure, according to Brenda. She said they inserted a feeding tube in his abdomen because he stopped eating.

When Spinks was put on a ventilator in November, Brenda said, she resisted efforts to get her to sign a do-not-resuscitate order.

“I just couldn’t do it,’’ she said. “It was horrible because there were a few times I didn’t think he was going to make it. I just tried to have hope. A lot of people praying.''

While Brenda was reflecting on the ordeal during a recent interview, the sound of clatter came from the kitchen.

“What are you doing, Leon?’’ she said.

“Nothing,’’ he said.

“That's what you always say,'' Brenda said, and later she found a shattered bottle of non-alcoholic beer in a freezer drawer.

Later that evening, Brenda, Spinks and Sam drove to Remnant Ministries, a church in Las Vegas where former NFL quarterback Randall Cunningham is the pastor. One of the churchgoers sang to Spinks when he was in an Intensive Care Unit and several others visited him in the hospital and the congregation has continued to pray for his recovery, Brenda said.

On that recent night, Spinks and Brenda made it in time for the benediction and found seats in the balcony.

During one song, Brenda leaned in close to Spinks and sang the refrain.

“I’m just so happy that he’s here and we’re just going to keep working at making things better,'' she said. "We’re not going to give up. We’re not throwing in the towel."

The latest Tweets from Leon Spinks (@LeonNeonSpinks). Official Twitter Account of World Heavyweight Champion Boxer LEON NEON SP

THAT OTHER CRISIS OF CAPITALISM
Extreme Weather Events Expose Vulnerability of Crops Globally


Atul Prakash and Shruti Srivastava
MARCH 11/2020

(Bloomberg) -- The world is on course to record its warmest winter ever, unsettling global crop production and raising the risk of food inflation.

Thailand has been hit with its worst drought in 40 years, Europe witnessed its hottest winter ever, Australia and New Zealand are reeling with poor rainfall and in some parts of the U.S., warmer temperatures have contributed to wetter weather.

For markets, extreme weather conditions, coupled with the spread of the coronavirus across the world, have led to volatile prices. The United Nations Food Price Index, which tracks monthly changes in global prices of commonly-traded food commodities, jumped to the highest in five years in January, before slipping in February as the virus hurt demand for products like edible oils and meat.

But unpredictable weather events along with declining water availability in many areas will be key factors in determining food prices in the future, said Sonal Varma, chief economist for India and Asia ex-Japan at Nomura Singapore Ltd. “Climate change will be a very important driver of food prices in the medium term,” said Varma. “This is definitely a risk worth watching globally.”CommodityCountryPrice reactionWhat’s happening

Palm oil Malaysia and Indonesia Palm oil jumped 60% between July 2019 and January 2020, before slumping on coronavirus concerns Drought


Sugar Thailand U.S. sugar surged 38% between September and February, before trimming advance Drought

Wheat U.S. U.S. wheat climbed about 18% since a 16-month low in May Heavy rainfall
Europe Warm winter

Canola Canada Canola prices gained about 6.5% since hitting a four-year low in May Heavy rainfall and freezing temperatures

Grins Australia Wheat price in Australia climbed 17% since May Drought

Milk New Zealand Benchmark milk prices advanced 8% since August Drought

Warmer Europe

The last three months shattered winter heat records in Europe, with temperatures almost 1.4 degrees Celsius (34.52 degrees Fahrenheit) higher than the next warmest wintertime just four years ago.

Wheat crops have been lying dormant through a warmer winter, keeping plants from developing their usual hardiness against frost damage.

Incessant autumn rain added to the wonky weather, keeping British wheat plantings at the lowest in 40 years and also curbing the acreage in France. That’s left forecasters like Coceral and Strategie Grains already pegging the EU’s 2020 crop at least 5% below last season’s bumper harvest.
© Bloomberg Smaller Crop Ahead

Wet U.S. Soils

A warmer climate has contributed to drenched fields across the U.S. Winter-wheat plantings fell to their lowest in more than a century as the grain got harder to seed. That was especially true for soft red winter wheat, with sowings in critical states like Illinois slumping 25%.

Meanwhile, freezing temperatures, rain and snow that decimated plants and harvesting last quarter could hurt beet harvests in Minnesota, North Dakota, Montana, Wyoming and Nebraska. Near the Red River Valley, conditions were the worst in almost four decades, and growers left swathes of beets and corn unharvested.
 © Bloomberg Sugar has risen since September before paring gains

“We have a very, very fragile situation for our growers,” who are not making enough to cover expenses, said Luther Markwart, executive vice president for the sugar association.

Drought-Hit Thailand

The severe drought in Thailand slashed sugar production in one of the world’s biggest exporters of the sweetener. Sugar output may tumble about 30% to 9 million to 10 million tons because of the dry weather.

“This is the first time I’ve seen sugar cane dying in the fields from drought,” according to Nutthapol Asadathorn, executive director at Thai Roong Ruang Sugar Group, one of the largest millers.

Freezing Canada

A deluge of wet weather and freezing temperatures pummeled parts of the Canadian Prairies last fall, halting harvest and leaving some wheat and canola crops stranded in the field. Canada is the world’s largest canola grower and one of the biggest wheat exporters.

Parts of Manitoba were the wettest in four decades and there is a risk of a wetter-than-normal spring in parts of southern Manitoba and Saskatchewan, said Joel Widenor, a meteorologist with Commodity Weather Group.
Dry AustraliaIn the southern hemisphere, recent rains in Australia came too late to boost prospects for summer crop planting in most of Queensland and northern New South Wales after a prolonged drought caused record low soil moisture in some areas.

Summer crop planting is expected to have dropped by two-thirds, according to government estimates, with production to fall by a similar amount, after low soil moisture constrained planting. Crop handler GrainCorp Ltd. said it expects to make “minimal grain exports” in 2020.
“Hotspot” New ZealandAcross the Tasman sea in New Zealand, nearly all North Island regions have reached official “hotspot status,” which means they are experiencing significant soil moisture deficits, according to National Institute of Water and Atmospheric Research.

Fonterra is keeping a close eye on milk production and climate extremes, Managing Director Cooperative Affairs Mike Cronin told NZME’s The Country radio show.

El-Nino in Southeast Asia

A weaker El Nino last year brought unusual dryness in key oil palm areas in Indonesia and Malaysia, which will curb production this year, according to Ling Ah Hong, director of plantation consultant Ganling Sdn.

Palm oil production in Indonesia may grow less than 4 million tons this year due to the fallout from last year’s drought and haze and lack of fertilizer usage, according to the Indonesian Palm Oil Association.
Hot China

China witnessed warmer-than-usual weather conditions in 2019, the fifth warmest year since 1951, leading to drinking water shortages, reduced water flows to rivers and crop damage, according to the National Climate Center.

Dry, hot weather in some areas of north China in May hit grain filling of winter wheat crops, while persistent high temperatures in the area also damaged some summer corn crops.
Saline Vietnam

Rice crops in Vietnam, the world’s third-biggest exporter, are also suffering. A prolonged drought, coupled with an extensive buildup of salinity, have driven five provinces in the country’s rice bowl to declare a state of emergency.

The Mekong Delta, which produces more than half of Vietnam’s rice, has so far seen a total of 33,000 hectares of rice fields damaged, Vietnam National Television reported, citing latest data from the country’s department of water resources.

The government estimates drought and salinity will affect 362,000 hectares of rice and 136,000 hectares of fruit trees in the Delta this year.

--With assistance from Marvin G. Perez, Ainslie Chandler, Pratik Parija, Jen Skerritt, Siraphob Thanthong-Knight, Michael Hirtzer, Megan Durisin, Anatoly Medetsky, Mai Ngoc Chau and Anuradha Raghu.

To contact the reporters on this story: Atul Prakash in New Delhi at aprakash51@bloomberg.net;Shruti Srivastava in New Delhi at ssrivastav74@bloomberg.net

To contact the editor responsible for this story: Anna Kitanaka at akitanaka@bloomberg.net

For more articles like this, please visit us at bloomberg.com

©2020 Bloomberg L.P.
THE SNAG IS REPUBLICANS

House coronavirus package hits snag

Some Republicans are already expressing doubt that the Senate will approve the House package without changes. Sen. Tom Cotton (R-Ark.) predicted Monday on "Fox & Friends" that the House coronavirus bill as written will not pass the Senate, raising questions about its paid sick leave provisions.
"It doesn't go far enough and it doesn't go fast enough," Cotton said. "Most of the measures in this bill are something that the senators will support, I believe. ... But we worry that the bill setting up a new and complicated system relying on businesses giving paid sick leave and then getting a refundable tax credit that won't move quickly enough and could put pressure on those businesses to lay workers off."
AH BE STILL MY BLEEDING HEART, THE GOP IS WORRIED ABOUT WORKERS
NOT THEY WANT THAT TAX CREDIT PASSED FAST
Aaron MacLean, Cotton's legislative director, sent an email to his fellow legislative directors Monday, saying the Arkansas Republican "feels strongly that the Senate should not accept the Pelosi-Mnuchin plan as a given for 'Phase II.'” He is urging the Senate to "adopt its own plan for economic assistance" with tax rebates, changes to the qualifications for unemployment insurance and Temporary Assistance for Needy Families and a more expansive program for low-interest loans to businesses. He has made his view clear to the White House.

https://www.msn.com/en-us/news/politics/house-coronavirus-package-hits-snag/ar-BB11fRm7
Congress' coronavirus relief bill still doesn't actually guarantee paid sick leave for most American workers

IF BIDEN IS ELECTED PRESIDENT THIS WILL BE THE DEMOCRATS STANDARD PRACTICE 
LIKE IT WAS WITH OBAMA WHO TOOK A REPUBLICAN HEALTHCARE PROGRAM AND CALLED IT OBAMACARE.  

THEY NEEDED TO INCLUDE MORTGAGE AND RENT FORGIVENESS FOR THREE MONTHS.

Joseph Zeballos-Roig Mar. 16, 2020
Associated Press

House Democrats touted paid sick leave as a centerpiece of their emergency legislation last week, but it doesn't actually cover most American workers.

Up to 20 million people may not be covered by the sick leave policy.

Large companies employing 500 or more workers are exempt from complying, and small companies with fewer than 50 workers can lobby for an exemption.

"Any carve-out for employers puts workers at risk, and it becomes a public health concern," economist Elise Gould said.

House Democrats led by Speaker Nancy Pelosi touted a big win over the weekend when they passed emergency relief legislation for Americans hardest hit by the coronavirus crisis. They pointed in particular to the creation of a paid sick leave policy that would encourage employees to stay home and still get paid if they fall ill.

But the finer details of the bill reveal it doesn't actually cover everyone and it could leave out millions of workers.

The Families First Coronavirus Response Act — which will likely be passed in the Senate later this week — exempts companies employing over 500 workers from the provision extending 14 days of paid sick leave equal to 100% of a person's salary to anyone seeking medical care or needing to quarantine.


The legislation also extends paid family and medical leave for workers at two-thirds of their pay up to three months. The benefits expire after a year, and the federal government is footing the bill through tax credits.

But only smaller and mid-sized businesses must comply. And businesses with fewer than 50 employees can also lobby for an exemption through the Labor Department if they believe granting the benefit would bankrupt them. It's not immediately clear what that process would look like.

Pelosi's office did not immediately return a request for comment. But she said on Sunday she didn't back using federal funds to enact a policy that should already be in place among large corporations.

"I don't support U.S. taxpayer money subsidizing corporations to provide benefits to workers that they should already be providing," she wrote on Twitter. "House Democrats will continue to prioritize strong emergency leave policies as we fight to put #FamiliesFirst."
How the bill leaves out a substantial chunk of American workers from getting sick pay

Large employers (500 or more workers) make up over 54% of the labor force, per data from the Census Bureau. Among these companies, around 89% have some paid sick leave policies in place, though it averages out to eight days, according to data from the Labor Department.

That means large businesses usually offer fewer days of sick leave than what would be mandated if they were required to comply with the Families First Act. Public health experts have urged anyone who may have been exposed to or who shows symptoms of coronavirus to self-quarantine for 14 days.

Even then, around 6.5 million workers don't have access to paid sick leave at these large companies, according to the Bureau of Labor Statistics. Smaller businesses of 50 or fewer workers employ around 12.5 million workers who don't have sick pay, bringing the total number of workers who may not be impacted by the legislation at just over 20 million.

Elise Gould, a senior economist at the Economic Policy Institute, told Business Insider that providing pay to some workers who fall ill and must stay home was a positive first step.

But she said more needed to be done to keep people home without fear of losing a paycheck.

"It will expand coverage to millions of workers, but at the same time millions of them will fall through the cracks with the bill," Gould said. "The more people we send home, the more we flatten the curve," referring to efforts aimed at preventing the virus' spread to a point that's manageable for the nation's healthcare system.

Gould said she believed there wasn't a "good economic case" to exempt large businesses from the sick leave provisions.


"Any carve-out for employers puts workers at risk, and it becomes a public health concern," Gould said.

Studies have shown that cities and states that offer paid sick leave showed as much as 40% lower rates of influenza compared to those that didn't have a similar policy in place.
Some large companies are moving ahead to extend paid sick leave on their own. Target and Amazon are among them, The New York Times reported. Uber also said it would compensate drivers and delivery workers infected with coronavirus for up to 14 days.
UPDATED 
'Not for sale': Germany has reacted furiously to Trump's attempts to poach German scientists working on a coronavirus vaccine

Thomas Colson
Reuters


Germany is furious about reports that President Donald Trump offered German scientists "a billion dollars" for exclusive rights to a coronavirus vaccine to be used "only for the USA."

The German government said the reports were accurate.

The Trump administration, however, said claims the US would not share the vaccine had been "wildly overplayed."

Visit Business Insider's homepage for more stories.


German government ministers have reacted furiously to reports the Trump administration has tried to buy exclusive rights to a coronavirus vaccine being developed by a German firm.

An explosive report in the German newspaper Welt am Sonntag cited German government sources as saying the Trump administration offered a "billion dollars" to secure exclusive rights to a coronavirus vaccine being developed by the firm CureVac, "but only for the USA."

The German health ministry told Reuters the report was accurate: "We confirm the report in the Welt am Sonntag," a representative said.

Following the report, Germany's foreign minister, Heiko Maas, insisted on Sunday that the government would not allow President Donald Trump to push ahead with such a plan.

"German researchers play a leading role in drug and vaccine development, and we cannot allow others to seek exclusive results," he told the media group Funke.

"Germany is not for sale," the country's economy minister, Peter Altmaier, told the broadcaster ARD on Sunday, according to AFP.

Karl Lauterbach, a senior German politician and professor of health economics and epidemiology, tweeted in response to the story: "The exclusive sale of a possible vaccine to the USA must be prevented by all means. Capitalism has limits."

A US official told AFP on Sunday that the report was "wildly overplayed" and denied any vaccine would be exclusive to the US.

"We will continue to talk to any company that claims to be able to help," the person said. "And any solution found would be shared with the world."

Florian von der Muelbe, CureVac's chief production officer and cofounder, told Reuters last week that the company hoped to have an experimental vaccine ready by June or July so it could seek permission to start testing on humans.

He said a low-dose vaccine that the company hoped to develop could make it suitable for mass production within CureVac's existing facilities.

In a statement last week, CureVac said its outgoing CEO, Daniel Menichella, had been invited to the White House for a meeting with Trump to discuss strategies and opportunities for the production of a coronavirus vaccine.

"We are very confident that we will be able to develop a potent vaccine candidate within a few months," Menichella said in a statement.

CureVac denied "rumors of an acquisition" in a Sunday statement. The firm said it had been in contact with many organizations and global authorities but "abstains from commenting on speculations and rejects allegations about offers for the acquisition of the company or its technology."

Trump 'offers large sums' for exclusive access to coronavirus vaccine

German government tries to fight off aggressive takeover bid by US, say reports


Philip Oltermann in Berlin@philipoltermann Mon 16 Mar 2020

A researcher at the German biopharmaceutical

company CureVac demonstrates work on a 
vaccine for the coronavirus at its laboratory in Tübingen.
Photograph: Andreas Gebert/Reuters

The Trump administration has offered a German medical company “large sums of money” for exclusive access to a Covid-19 vaccine, German media have reported.

The German government is trying to fight off what it sees as an aggressive takeover bid by the US, the broadsheet Die Welt reports, citing German government circles.

The US president had offered the Tübingen-based biopharmaceutical company CureVac “large sums of money” to gain exclusive access to their work, wrote Die Welt.Q&A
How can I protect myself from the coronavirus outbreak?Show

According to an anonymous source quoted in the newspaper, Trump was doing everything to secure a vaccine against the coronavirus for the US, “but for the US only”.

The German government was reportedly offering its own financial incentives for the vaccine to stay in the country.

The German health minister Jens Spahn said that a takeover of the CureVac company by the Trump administration was “off the table”. CureVac would only develop vaccine “for the whole world”, Spahn said, “not for individual countries”.

Earlier, when approached about the report by the Guardian, the German health ministry would only confirm the accuracy of the quotes attributed to one of its spokespersons in the article.

“The federal government is very interested in vaccines and antiviral agents against the novel coronavirus being developed in Germany and Europe,” the spokesperson quoted in the original article had said. “In this regard the government is in an intensive exchange with the company CureVac.”

The German health ministry spokesperson declined the opportunity to correct any inaccuracies in Die Welt’s account.

With its headquarters in the south-western German city of Tübingen, CureVac also has sites in Frankfurt and Boston in the US. Linked with the German health ministry, it works closely with the Paul Ehrlich Institute, a research institution and medical regulatory body that is subordinate to the German health ministry.

On 11 March, CureVac released a statement that its CEO, the US citizen Daniel Menichella, was unexpectedly leaving the firm and would be replaced by the company’s founder, Ingmar Hoerr.

At the start of the month, Menichella was invited to the White House in Washington to discuss strategy for the rapid development and production of a coronavirus vaccine with Trump, the vice-president, Mike Pence, and members of the White House coronavirus task force.

The White House has been contacted for comment.


President Trump reportedly tried to poach German scientists working on a cure for coronavirus and offered cash so the vaccine would be exclusive to the US


Business Insider•March 15, 2020

Employee Philipp Hoffmann, of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020. Picture taken on March 12, 2020. REUTERS/Andreas Gebert

President Donald Trump reportedly tried to poach German scientists working on a cure for the coronavirus so he could secure exclusive rights to a potential vaccine for the US only.

Newspaper WELT am Sonntag reported that Trump's administration had offered large sums of cash to Germany-based biotech company CureVac to secure rights for the vaccine work, "but only for the USA."

The German government is battling back, offering financial incentives to the company to remain in Germany.

Karl Lauterbach, a senior German politician and professor of epidemiology, said in response to the report: "The exclusive sale of a possible vaccine to the USA must be prevented by all means. Capitalism has limits."

CureVac said it has been in contact with many organizations and global authorities, but denied "rumors of an acquisition" in a statement Sunday to Business Insider.

President Trump reportedly tried to recruit German scientists working on a cure for the coronavirus and offered large sums of money to secure exclusive rights to their work for the US, according to a report which was confirmed by the German government.

Prominent German newspaper WELT am Sonntag reported that Trump had offered large sums of money to lure the Germany-based company CureVac to the United States and to secure exclusive rights to a vaccine.

The firm works with the federally-owned Paul Ehrlich Institute for Vaccines and Biomedical Medicines on a cure for the coronavirus.

CureVac denied "rumors of an acquisition" in a March 15 statement. The biotech company said it has been in contact with many organizations and global authorities, but "abstains from commenting on speculations and rejects allegations about offers for acquisition of the company or its technology."

A German government source said Trump was trying hard to find a coronavirus vaccine for the United States, "but only for the USA."

The newspaper said the German government is fighting back by offering financial incentives to the company if it remains in Germany.

A German health ministry spokesperson told WELT am Sonntag that the government was involved in "intensive" discussions with CureVac about keeping the company headquartered in the UK.

"The German government is very interested in ensuring that vaccines and active substances against the new coronavirus are also developed in Germany and Europe," the newspaper quoted a Health Ministry official as saying.

"In this regard, the government is in intensive exchange with the company CureVac."

In a separate statement, the health ministry told Reuters that the WELT am Sonntag report was accurate: "We confirm the report in the WELT am Sonntag," a spokesperson said.

Florian von der Muelbe, CureVac's chief production officer and co-founder, told Reuters last week that the company hoped to have an experimental vaccine ready by June or July so they could seek permission to start testing on humans.

He said a low-dose vaccine that the company hoped to develop could make it suitable for mass production within CureVac's existing facilities.

In a statement last week, CureVac said that outgoing chief executive Daniel Menichella had been invited to the White House for a meeting with President Trump to discuss strategies and opportunities for the production of a coronavirus vaccine.

"We are very confident that we will be able to develop a potent vaccine candidate within a few months," Menichella said in a statement.

Karl Lauterbach, a senior German politician and professor of health economics and epidemiology, tweeted in response to the story: "The exclusive sale of a possible vaccine to the USA must be prevented by all means. Capitalism has limits."



Germany tries to halt U.S. interest in firm working on coronavirus vaccine

Paul CarrelAndreas Rinke

BERLIN (Reuters) - Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move its research to the United States, prompting German politicians to insist no country should have a monopoly on any future vaccine.

German government sources told Reuters on Sunday that the U.S. administration was looking into how it could gain access to a potential vaccine being developed by a German firm, CureVac.

Earlier, the Welt am Sonntag German newspaper reported that U.S. President Donald Trump had offered funds to lure CureVac to the United States, and the German government was making counter-offers to tempt it to stay.

Responding to the report, the U.S. ambassador to Germany, Richard Grenell, wrote on Twitter: “The Welt story was wrong.”

A U.S. official said: “This story is wildly overplayed ... We will continue to talk to any company that claims to be able to help. And any solution found would be shared with the world.”

A German Health Ministry spokeswoman, confirming a quote in the newspaper, said: “The German government is very interested in ensuring that vaccines and active substances against the new coronavirus are also developed in Germany and Europe.”

“In this regard, the government is in intensive exchange with the company CureVac,” she added.

Welt am Sonntag quoted an unidentified German government source as saying Trump was trying to secure the scientists’ work exclusively, and would do anything to get a vaccine for the United States, “but only for the United States.”


German Interior Minister Horst Seehofer told a news conference that the government’s coronavirus crisis committee would discuss the CureVac case on Monday.

CureVac issued a statement on Sunday, in which it said: “The company rejects current rumors of an acquisition”.

CureVac’s main investor Dietmar Hopp said he was not selling and wanted CureVac to develop a coronavirus vaccine to “help people not just regionally but in solidarity across the world.”

“I would be glad if this could be achieved through my long-term investments out of Germany,” he added.

A German Economy Ministry spokeswoman said Berlin “has a great interest” in producing vaccines in Germany and Europe.

She cited Germany’s foreign trade law, under which Berlin can examine takeover bids from non-EU, so-called third countries “if national or European security interests are at stake”.


EXPERIMENTAL VACCINE

Florian von der Muelbe, CureVac’s chief production officer and co-founder, told Reuters last week the company had started with a multitude of coronavirus vaccine candidates and was now selecting the two best to go into clinical trials.

The privately-held company based in Tuebingen, Germany hopes to have an experimental vaccine ready by June or July to then seek the go-ahead from regulators for testing on humans.

On its website, CureVac said CEO Daniel Menichella early this month met Trump, Vice President Mike Pence, members of the White House Coronavirus Task Force and senior representatives of pharmaceutical and biotech companies to discuss a vaccine.

CureVac in 2015 and 2018 secured financial backing for development projects from its investor the Bill & Melinda Gates Foundation, working on shots to prevent malaria and influenza.

In the field of so-called mRNA therapeutics, CureVac competes with U.S. biotech firm Moderna and German rival BioNTech, which Pfizer (PFE.N) has identified as a potential collaboration partner.

Drugs based on mRNA provide a type of genetic blueprint that can be injected into the body to instruct cells to produce the desired therapeutic proteins. That contrasts with the conventional approach of making these proteins in labs and bio-reactors.

In the case of vaccines, the mRNA prompts body cells to produce so-called antigens, the tell-tale molecules on the surface of viruses, that spur the immune system into action.

Companies working on other coronavirus-vaccine approaches include Johnson & Johnson (JNJ.N) and INOVIO Pharmaceuticals, Inc. (INO.O).


US, Germany battle for virus vaccine surpremacy

AFP•March 14, 2020

US President Donald Trump (C, pictured with members of the Coronavirus Task Force at the White House) reportedly is trying to poach German scientists working on an experimental vaccine against the virus (AFP Photo/JIM WATSON)More

Berlin (AFP) - The United States and Germany are vying to produce an exclusive vaccine against the coronavirus which is being developed in a German laboratory, Die Welt daily reported Saturday

According to the paper, US President Donald Trump is trying to poach German scientists working on an experimental vaccine against a global health threat that has now killed some 5,500 people with a view to having an exclusive licence rolled out in the United States.

Such a vaccine would be "only for the United States," a source close to the German government told Die Welt, though Berlin would reportedly is looking to make offers of its own to biotech firm CureVac, based in the German state of Thuringia.

The company, founded in 2000, has other sites in Frankfurt and Boston.-

The firm markets itself as specialising in "development of treatments against cancer, antibody-based therapies, treatment of rare illnesses and prophylactic vaccines."

The lab is currently working in tandem with the Paul-Ehrlich Institute, linked to the German ministry of health.

It specialises in vaccine research.

"The German government is very interested in having the development of vaccines and active substances against the novel coronavirus undertaken in Germany and Europe," a health ministry spokesman told Die Welt, adding that the government was in "intensive" talks with CureVac.

As CureVac CEO, Daniel Menichella found himself invited on March 2 to the White House to meet with Trump, his vice-president Mike Pence and representatives of pharma companies working on how to respond to the pandemic, the company revealed on its website without indicating if financial offers had been put on the table.

"We are very confident that we will be able to develop a potent vaccine candidate within a few months," CureVac quoted Menichella -- who has since given way to founder and incoming CEO Ingmar Hoerr -- as saying following his Washington visit.

---30---